Vetr upgraded shares of UnitedHealth Group Inc. (NYSE:UNH) from a buy rating to a buy rating in a report published on Friday morning.
A number of other research analysts have also recently weighed in on the company. Jefferies Group reaffirmed a buy rating and set a $163.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 4th. Evercore ISI assumed coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They set a buy rating and a $155.00 price objective on the stock. Cowen and Company set a $150.00 price objective on UnitedHealth Group and gave the company a buy rating in a research report on Tuesday, September 6th. Sanford C. Bernstein reaffirmed an outperform rating and set a $178.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, September 6th. Finally, Leerink Swann reaffirmed an outperform rating on shares of UnitedHealth Group in a research report on Sunday, August 21st. One equities research analyst has rated the stock with a hold rating, twenty-five have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of Buy and a consensus price target of $155.35.
UnitedHealth Group (NYSE:UNH) opened at 134.75 on Friday. UnitedHealth Group has a 12 month low of $107.51 and a 12 month high of $144.48. The company has a market capitalization of $128.33 billion, a PE ratio of 21.09 and a beta of 0.57. The firm’s 50-day moving average is $137.48 and its 200-day moving average is $136.51.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. Equities analysts anticipate that UnitedHealth Group will post $7.90 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were issued a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 1.86%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is 39.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the sale, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.65% of the stock is owned by company insiders.
Several large investors have recently modified their holdings of UNH. Mckinley Capital Management LLC Delaware boosted its stake in shares of UnitedHealth Group by 2,666.3% in the first quarter. Mckinley Capital Management LLC Delaware now owns 65,341 shares of the healthcare conglomerate’s stock worth $8,422,000 after buying an additional 62,979 shares during the period. Wrapmanager Inc. boosted its stake in shares of UnitedHealth Group by 4.3% in the first quarter. Wrapmanager Inc. now owns 17,546 shares of the healthcare conglomerate’s stock worth $2,262,000 after buying an additional 717 shares during the period. RMB Capital Management LLC boosted its stake in shares of UnitedHealth Group by 35.2% in the first quarter. RMB Capital Management LLC now owns 2,895 shares of the healthcare conglomerate’s stock worth $373,000 after buying an additional 754 shares during the period. Rehmann Capital Advisory Group boosted its stake in shares of UnitedHealth Group by 5.4% in the first quarter. Rehmann Capital Advisory Group now owns 9,250 shares of the healthcare conglomerate’s stock worth $1,192,000 after buying an additional 472 shares during the period. Finally, Prudential Financial Inc. boosted its stake in shares of UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock worth $316,927,000 after buying an additional 790,220 shares during the period. Institutional investors and hedge funds own 85.78% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.